Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Publication year range
1.
Clin Drug Investig ; 29(11): 739-46, 2009.
Article in English | MEDLINE | ID: mdl-19813777

ABSTRACT

BACKGROUND AND OBJECTIVE: Calcium channel antagonists (calcium channel blockers [CCBs]) are often used in the treatment of patients with hypertension to achieve strict blood pressure (BP) targets. In the present study, we compared the antihypertensive effects (determined by home BP [HBP] measurements) and the effects on renal function of benidipine (hydrochloride) and amlodipine (mesylate), a commonly used CCB. METHODS: Changes in HBP and urinary albumin excretion (UAE) were investigated in 47 benidipine and 37 amlodipine recipients with essential hypertension and albuminuria between January 2007 and December 2007. Both benidipine and amlodipine significantly reduced morning and evening HBP over a 12-month period. RESULTS: Both medications also significantly reduced UAE compared with pretreatment values; however, the reduction in UAE observed in the benidipine group occurred independent of the drug's antihypertensive effects, whereas a positive correlation was shown between the reduction in morning systolic BP and UAE in the amlodipine group. CONCLUSIONS: These results demonstrate that benidipine favourably affects renal function in patients with essential hypertension compared with amlodipine, suggesting that the clinical benefits of benidipine as an antihypertensive drug include a renoprotective effect.


Subject(s)
Amlodipine/therapeutic use , Blood Pressure/drug effects , Calcium Channel Blockers/therapeutic use , Dihydropyridines/therapeutic use , Glomerular Filtration Rate/drug effects , Hypertension/drug therapy , Adult , Aged , Albuminuria/chemically induced , Calcium Channels, T-Type/drug effects , Female , Humans , Hypertension/physiopathology , Male , Middle Aged , Retrospective Studies
2.
Intern Med ; 47(5): 453-7, 2008.
Article in English | MEDLINE | ID: mdl-18310982

ABSTRACT

A 50-year-old man without family history of metabolic bone disease was referred to our hospital with a 5-year history of progressively worsening spinal and bilateral diffuse leg pain and proximal muscle weakness. Two years before admission, he was diagnosed as ankylosing spondylitis by a rheumatologist and was maintained on low-dose prednisone therapy without benefit. He developed progressive spinal and thoracic deformities, resulting in a 10 cm loss in height in the preceding 2 years. On physical examination, marked thoracic kyphosis and pectus carinatum was noted. Plain radiograph revealed pseudofracture in the right femoral neck. Laboratory findings showed a normal level of serum calcium, elevated level of serum alkaline phosphatase and inappropriately increased urinary phosphate excretion despite extreme hypophosphatemia. He was diagnosed as adult-onset hypophosphatemic osteomalacia caused by renal phosphate wasting. Serum fibroblast growth factor 23 was the upper limit of normal despite extreme hypophosphatemia and no neoplastic lesion potentially inducing hypophosphatemic osteomalacia could be identified in a thorough search including imaging studies of his entire body. Oral administration of phosphate and activated vitamin D together with dipyridamole relieved the persistent pain and weakness, and he became fully ambulatory.


Subject(s)
Fibroblast Growth Factors/blood , Hypophosphatemia/drug therapy , Osteomalacia/blood , Osteomalacia/etiology , Phosphates/blood , Age of Onset , Bone Density Conservation Agents/therapeutic use , Dipyridamole/therapeutic use , Fibroblast Growth Factor-23 , Fibroblast Growth Factors/metabolism , Humans , Hypophosphatemia/complications , Male , Middle Aged , Phosphodiesterase Inhibitors/therapeutic use , Vitamin D/therapeutic use
3.
Intern Med ; 46(13): 1047-53, 2007.
Article in English | MEDLINE | ID: mdl-17603250

ABSTRACT

A 59-year-old woman without underlying disease was admitted to a local hospital because of lung abscess, cytopenias and renal failure. 3 days before admission, she was diagnosed as influenza infection and was under antiviral therapy. Blood cultures were positive for methicillin-sensitive Staphylococcus aureus (MSSA). She was transferred to our hospital on the 15th day at the local hospital because the clinical manifestations could not improve even though she was treated with multiple intravenous antibiotics directed against MSSA. Sputum cultures yielded methicillin-resistant S. aureus (MRSA) producing toxic shock syndrome toxin-1 (TSST-1) and serologic test indicated hypercytokinemia. She was diagnosed as rapidly progressive glomerulonephritis and hemophagocytic syndrome associated with staphylococcal infection. The pulmonary lesions, cytopenias and renal dysfunction improved as a result of long-term antimicrobial treatment including vancomycin, hemodialysis, short-term administration of corticosteroid and other supportive cares. She was finally weaned from hemodialysis on the 73rd hospital day. In recent years, the number of cases of S. aureus producing TSST-1 and enterotoxin has been increasing and in cases of staphylococcal infections, close attention should be given to toxin-mediated as well as non-toxin-mediated clinical manifestations.


Subject(s)
Glomerulonephritis/microbiology , Lymphohistiocytosis, Hemophagocytic/diagnosis , Pneumonia, Bacterial/microbiology , Staphylococcal Infections/diagnosis , Combined Modality Therapy , Community-Acquired Infections/complications , Community-Acquired Infections/microbiology , Community-Acquired Infections/therapy , Disease Progression , Female , Follow-Up Studies , Glomerulonephritis/complications , Glomerulonephritis/therapy , Humans , Lymphohistiocytosis, Hemophagocytic/complications , Lymphohistiocytosis, Hemophagocytic/therapy , Middle Aged , Pneumonia, Bacterial/complications , Pneumonia, Bacterial/therapy , Severity of Illness Index , Staphylococcal Infections/complications , Staphylococcal Infections/drug therapy , Staphylococcus aureus/isolation & purification
4.
Intern Med ; 46(6): 317-23, 2007.
Article in English | MEDLINE | ID: mdl-17380002

ABSTRACT

A 56-year-old woman was admitted because of a high fever, right ptosis, chemosis, proptosis and ocular muscle palsy. Cranial MRI revealed a cavernous sinus thrombosis and a subarachnoid abscess. Carotid angio-gram demonstrated marked stenosis as well as aneurismal formation of the right internal carotid artery at the intracavernous portion. Chest radiograph showed bilateral multiple pulmonary nodules, some of which contained a cavity. Blood culture was positive for Streptococcus constellatus. She was diagnosed with septic cavernous sinus thrombosis complicated by narrowing of the internal carotid artery, subarachnoid abscess and multiple pulmonary septic emboli. She recovered with partial ocular sequelae as a result of seven weeks of intravenous antimicrobial therapy.


Subject(s)
Brain Abscess/etiology , Carotid Stenosis/etiology , Cavernous Sinus Thrombosis/complications , Pulmonary Embolism/etiology , Streptococcal Infections/complications , Streptococcus constellatus , Anti-Bacterial Agents/therapeutic use , Brain Abscess/diagnosis , Brain Abscess/therapy , Carotid Stenosis/diagnosis , Carotid Stenosis/therapy , Cavernous Sinus Thrombosis/diagnosis , Cavernous Sinus Thrombosis/therapy , Female , Humans , Middle Aged , Orbital Diseases/diagnosis , Orbital Diseases/etiology , Orbital Diseases/therapy , Pulmonary Embolism/diagnosis , Pulmonary Embolism/therapy , Streptococcal Infections/diagnosis , Streptococcal Infections/microbiology , Streptococcal Infections/therapy , Streptococcus constellatus/isolation & purification , Subarachnoid Space , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...